100Xfounder
Get Featured

Developing an Innovative Endoscopic Outpatient Procedure to Improve Glycemic Control for Type 2 Diabetes Healthcare Medical Devices

About Fractyl Labs

The Problem Fractyl Labs addresses a core healthcare pain point: fragmented operations, slow decision cycles, and poor visibility across teams. Organizations in this market often rely on disconnected tools, which creates delays, revenue leakage, and inconsistent customer outcomes.

The Solution Developing an Innovative Endoscopic Outpatient Procedure to Improve Glycemic Control for Type 2 Diabetes Healthcare Medical Devices In practice, Fractyl Labs centralizes critical workflows, automates repetitive coordination, and gives operators a real-time system of record. This reduces manual overhead and improves execution quality at scale.

Why it's growing With the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Fractyl Labs is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.

Culture The team operates in a fast-paced environment focused on healthcare innovation, product velocity, and customer-centric execution. Their culture emphasizes ownership, experimentation, and measurable outcomes.

Why it Matters

Fractyl Labs matters now because with the rise of digitized healthcare workflows, preventive analytics, and patient-first digital journeys, Fractyl Labs is positioned to capture sustained demand. Buyers now prioritize speed, reliability, and clear ROI, and the company aligns directly with those purchasing criteria.

Funding Snapshot

Total Funding: $100.00MLast Round: Series F Bessemer, $100M Series F in 2021All Rounds: 1
  • Series FBessemer, $100M Series F in 2021

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

Tech Stack

PythonGCPBigQueryReact

Last updated: February 23, 2026

Fractyl Labs intelligence brief

This profile combines core company context with linked founder, funding, and newsroom routes so readers can evaluate business momentum without switching across multiple tools. Use it as a baseline for comparing peers in the same industry and stage.

For deeper validation, pair this page with founder profile, company news coverage, and stage-based funding hubs to contextualize updates against wider market movement.

Related Companies

Alternatives in Healthcare with comparable market signals.

Discover Now

Newsroom and topic pages connected to Fractyl Labs.

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

FAQs About Fractyl Labs

Common questions people ask about this profile.

What is Fractyl Labs?

Developing an Innovative Endoscopic Outpatient Procedure to Improve Glycemic Control for Type 2 Diabetes Healthcare Medical Devices

Who founded Fractyl Labs?

Fractyl Labs is associated with Fractyl Labs Team on 100Xfounder.

Where is Fractyl Labs located?

Fractyl Labs is listed in Boston, Massachusetts, USA.

What stage is Fractyl Labs in?

Fractyl Labs is currently mapped to Series F. Funding context: Bessemer, $100M Series F in 2021

What is the latest funding round of Fractyl Labs?

Fractyl Labs's latest tracked round is Series F Bessemer, $100M Series F in 2021. Total tracked rounds: 1.

Is Fractyl Labs hiring now?

Fractyl Labs hiring status: Open Roles.

What technologies does Fractyl Labs use?

Fractyl Labs is associated with Python, GCP, BigQuery, and React.

Is Fractyl Labs verified on 100Xfounder?

Yes. Fractyl Labs is currently marked verified on 100Xfounder as of March 3, 2026.

How can users connect with Fractyl Labs founders?

Users can open founder profiles, use listed company links, and track signal updates directly from the 100Xfounder directory.